Clinical Trial Update: OatMeal and Insulin Resistance: OMA-IR [Phase 3]

View source ↗

Summary

Phase 3 trial update showing completion of the OMA-IR study evaluating an oatmeal-based intervention for insulin resistance in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Diabetes Mellitus Type 2, Insulin Resistance | Phase 3 | Status: COMPLETED